molecules of the month

“compound 37”

ATG7 E1 substrate-assisted covalent inhibitor

autophagy inhibition in vivo (150 mg/kg SC)

from focused HTS of adenosine sulfamates

Bioorg. Med. Chem., Aug. 4, 2020

Takeda, Cambridge, MA

Structure of compound 37
1 min read

“compound 37” is an inhibitor of the ATG7 E1 ligase through an interesting substrate-assisted covalent mechanism. Rather than covalently modify ATG7 directly, the molecule reacts with the E1 ligase substrate, Ubl, to form a Ubl-inhibitor adduct which non-covalently inhibits ATG7. This mechanism has been employed by Takeda successfully in the past against a number of other related targets such as NEDD8-activating enzyme. Compound 37 is one of three molecules from this article demonstrating in vivo inhibition of the autophagy process.

request a trial

You don’t have time to read everything, but you can’t afford to fall behind.

Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples.

Get ahead now by requesting a trial.

already a member? log in: